Skip to main content
Caplight Logo









Omnix Medical Ltd.

Omnix Medical Ltd.

Private
JerusalemHealthcare & Life Scienceshttps://omnixmedical.com/

Last Round

Series C

Oct 15, 2025

Total Funding Raised

$73.1M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Omnix Medical Ltd. is a biopharmaceutical company that develops next-generation antimicrobial peptides to treat drug-resistant bacterial infections.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Non-AI

Keywords

anti-infective agentmulti-drug resistant bacteriaMDRantibiotic resistancesuperbugbiopharmaceuticaldrug discoveryclinical-stage biotechantimicrobial peptideclinical trialsdrug developmentOMN6new antibiotics

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Omnix Medical Ltd. Comparables

Compare Omnix Medical Ltd. with similar companies based on industry and business-model similarity.

Omnix Medical Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
VenatoRx Pharmaceuticals
81%
Spero Therapeutics, Inc.
81%
Bioversys
79%

Omnix Medical Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series COct 15, 2025
Series COct 15, 2025
GrantJan 25, 2021
Series ANov 20, 2020
SeedDec 1, 2018

Key People

Founding team and executive leadership

Moshik Cohen-Kutner

Co Founder CEO

Founding Team

Omnix Medical Ltd. Investors

Notable investors and investment history

Omnix Medical Ltd. investors
InvestorRounds
European Union's Horizon Research and Innovation programGrant
Tal VenturesSeries A
European Innovation Council FundGrant, Series C
Israel Innovation AuthoritySeries A, Seed
Entrée CapitalSeries C, Series A
Tal VenturesSeries C, Series A
Xenia Venture CapitalSeries A, Series C, Seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 1, 2026

    Open roles increased to 4, 3.3x the trailing average.

  • Jun 21, 2026

    Monthly visitors increased 302% MoM, reaching 796.

Omnix Medical Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Omnix Medical Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Omnix Medical Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersJerusalem
Employee Range26
Year Founded2015
Last FundingOct 15, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?